UroGen settles JELMYTO patent litigation with Teva
Go back to UroGen settles JELMYTO patent litigation with Teva| (NASDAQ: URGN) | Delayed: 35.42 +0.27 (0.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.15 | 52 Week High | $ | |||
| Open | $35.11 | 52 Week Low | $ | |||
| Day High | $36.08 | P/E | N/A | |||
| Day Low | $34.61 | EPS | $ | |||
| Volume | 581,793 | |||||

